Elanco Animal Health Incorporated (ELAN) — closed signal from September 24, 2025
Near target Published before the outcome was known, scored automatically when the window closed on December 23, 2025 — +16.5% at the close.
Predicted vs. what happened
What happened
Came within reach: 97% of the predicted growth at its peak, just short of the target.
The thesis — published September 24, 2025
Elanco's near-term story is driven by fresh news. Being added to the S&P MidCap 400 can trigger automatic buying from investment funds, and the FDA removed a vaccine risk warning from Zenrelia, easing concern around a key product. The stock has fallen but is starting to stabilize. Over the next 0-3 months we expect a rebound from these forces, but we would stay disciplined if momentum fades. This is a short-term view while fundamentals improve.
Primary drivers
- Joining the S&P MidCap 400 can spark automatic fund buying demand
- FDA removed a warning on Zenrelia, easing safety worries for this key product
- Shares fell hard but are starting to stabilize and recover in recent trading
- Business results trail the stock move, so this stays a short-term idea
How it played out
ELAN: target was not reached after a 24.2% peak
Lyra published ELAN at 19.08 on 2025-09-24 as a short-term rebound idea. The thesis expected 25% growth over 0-3 months. It pointed to S&P MidCap 400 inclusion, the FDA removing a Zenrelia vaccine risk warning, recent stabilization after a hard fall, and still-lagging business results.
Inside the window, ELAN rose to 23.7 on 2025-11-26, a 24.2% peak gain. The target was 23.84, so it stayed below the target. It never got there. By 2025-12-23, the stock ended at 22.22. The thesis mostly played out on direction and size, but it missed the published target.
What happened during the window
On 2025-12-09, Investor's Business Daily reported that Elanco had reiterated its fourth-quarter and 2025 guidance at its investor day. The same report said third-quarter revenue rose 10%.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.